tiprankstipranks
Trending News
More News >
Clal Biotechnology Industries Ltd (IL:CBI)
:CBI
Israel Market

Clal Biotech (CBI) Financial Statements

Compare
0 Followers

Clal Biotech Financial Overview

Clal Biotech's market cap is currently 52.07M. The company's EPS TTM is -0.397; its P/E ratio is -0.84; Clal Biotech is scheduled to report earnings on ―, and the estimated EPS forecast is ―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue 433.00K 104.00K 370.00K 224.00K 206.00K
Gross Profit -183.00K 104.00K 370.00K 224.00K 206.00K
Operating Income -6.34M -10.18M -27.42M -77.59M 40.15M
EBITDA -6.34M -24.02M 64.22M -55.08M 13.23M
Net Income -62.46M -31.05M -61.74M -89.58M 109.03M
Balance Sheet
Cash & Short-Term Investments 5.01M 13.36M 12.88M 53.05M 186.50M
Total Assets 67.69M 158.39M 182.69M 444.92M 614.03M
Total Debt 20.84M 35.76M 36.73M 11.68M 7.74M
Net Debt 16.89M 30.03M 1.90M -41.37M -60.42M
Total Liabilities 21.52M 36.98M 37.79M 106.55M 100.24M
Stockholders' Equity 36.63M 99.36M 126.03M 172.59M 306.35M
Cash Flow
Free Cash Flow -6.48M -8.52M -60.31M -42.92M -36.41M
Operating Cash Flow -6.48M -8.51M -59.04M -41.33M -33.23M
Investing Cash Flow 20.00M 7.66M -10.96M 79.18M 70.78M
Financing Cash Flow -15.55M -1.18M 20.05M -51.54M -2.38M
Currency in ILS

Clal Biotech Earnings and Revenue History

Clal Biotech Debt to Assets

Clal Biotech Cash Flow

Clal Biotech Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.